Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Published:2013-10-29 Issue:6 Volume:58 Page:1941-1952
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Staels Bart¹²³⁴,Rubenstrunk Anne⁵,Noel Benoit⁵,Rigou Géraldine⁵,Delataille Philippe⁵,Millatt Lesley J.⁵,Baron Morgane¹²³⁴,Lucas Anthony¹²³⁴,Tailleux Anne¹²³⁴,Hum Dean W.⁵,Ratziu Vlad⁶,Cariou Bertrand⁷,Hanf Rémy⁵

Affiliation:

1. Institut Pasteur de Lille; Lille France

2. Inserm; UMR1011 Lille France

3. Université Lille Nord de France; Lille France

4. Université Droit et Santé de Lille; Lille France

5. Genfit SA; Loos France

6. Department of Hepatogastroenterology; Pitie-Salpetriere University Hospital, University Pierre et Marie Curie Paris VI; Paris France

7. Department of Endocrinology; l'Institut du Thorax, Nantes University Hospital; Nantes France

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26461/fullpdf

Reference45 articles.

1. Recent advances in nonalcoholic fatty liver disease;Cheung;Curr Opin Gastroenterol,2010

2. Nonalcoholic fatty liver disease: from steatosis to cirrhosis;Farrell;Hepatology,2006

3. NASH: a hidden and silent fibroser finally revealed?;Ratziu;J Hepatol,2005

4. The natural history of nonalcoholic fatty liver disease: a population-based cohort study;Adams;Gastroenterology,2005

5. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis;Ratziu;Hepatology,2002

Cited by 357 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities;European Journal of Medicinal Chemistry;2024-11

2. Non-Coding RNAs Involved in the Regulation of Signaling Pathways as Possible Markers of Non-Alcoholic Fatty Liver Disease Progression;Biology Bulletin;2024-09-10

3. Expression of Vascular Adhesion Protein-1 and Thrombospondin-1 in Gingival Crevicular Fluid of Patients with Periodontitis and Non-Alcoholic Fatty Liver Disease;Journal of Inflammation Research;2024-08

4. Effects of elafibranor on liver fibrosis and gut barrier function in a mouse model of alcohol-associated liver disease;World Journal of Gastroenterology;2024-07-28

5. Evaluating the safety and efficacy of seladelpar for adults with primary biliary cholangitis;Expert Opinion on Pharmacotherapy;2024-07-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3